BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 16881107)

  • 1. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
    Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
    J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis.
    Westermark P; Sletten K; Eriksson M
    Lab Invest; 1979 Nov; 41(5):427-31. PubMed ID: 502474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis.
    Ueno T; Takeda K; Nagata M
    Nephrol Dial Transplant; 2012 Feb; 27(2):633-9. PubMed ID: 21771754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
    Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloidosis is frequently undetected in patients with rheumatoid arthritis.
    Koivuniemi R; Paimela L; Suomalainen R; Tornroth T; Leirisalo-Repo M
    Amyloid; 2008 Dec; 15(4):262-8. PubMed ID: 19065298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria.
    Falck HM; Törnroth T; Wegelius O
    Clin Nephrol; 1983 Mar; 19(3):137-42. PubMed ID: 6839564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The problem of rheumatoid nephropathy].
    Kanevskaia MZ; Varshavskiĭ VA
    Ter Arkh; 2003; 75(5):24-9. PubMed ID: 12847893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of thirty-four rheumatoid arthritis patients with renal amyloidosis, including twelve given alkylating agents.
    Couverchel L; Maugars Y; Prost A
    Rev Rhum Engl Ed; 1995 Feb; 62(2):79-85. PubMed ID: 7600076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis.
    Maezawa A; Hiromura K; Mitsuhashi H; Tsukada Y; Kanai H; Yano S; Naruse T
    Clin Nephrol; 1994 Jul; 42(1):30-2. PubMed ID: 7923963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic associations of clinical and histopathological features in renal amyloidosis.
    Min KW; Na W; Jang SM; Park MH
    Postgrad Med J; 2011 Aug; 87(1030):529-34. PubMed ID: 21690257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An AA-amyloidosis course in patients with rheumatoid arthritis].
    Sarkisova IA; Rameev VV; Varshavskiĭ VA; Golitsyn EP; Kozlovskaia LV
    Ter Arkh; 2006; 78(5):31-6. PubMed ID: 16889046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal amyloidosis in rheumatoid arthritis.
    Pruzanski W
    J Rheumatol; 2007 Apr; 34(4):889; author reply 889. PubMed ID: 17407247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival].
    Esteve V; Almirall J; Ponz E; García N; Ribera L; Larrosa M; Andreu X; García M
    Nefrologia; 2006; 26(2):212-7. PubMed ID: 16808259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical outcome of renal amyloidosis.
    Odabas AR; Cetinkaya R; Selcuk Y; Erman Z; Bilen H
    Int J Clin Pract; 2002 Jun; 56(5):342-4. PubMed ID: 12137441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory findings and serum levels of amyloid A and soluble interleukin-2 receptors in patients with renal amyloidosis].
    Rysavá R; Merta M; Tesar V; Zabka J; Spicka I; Stejskalová A; Vernerová Z
    Cas Lek Cesk; 1998 Feb; 137(4):107-9. PubMed ID: 9531732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The possible pathogenesis of AA type amyloidosis in a patient with ulcerative colitis and renal cell carcinoma].
    Kostadinova-Kunovska S; Petrusevska G; Grcevska L; Banev S; Dzikova S; Bogoeva B; Polenaković M
    Acta Med Croatica; 2006 Jun; 60(3):251-4. PubMed ID: 16933838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in reactive amyloidosis associated with rheumatoid arthritis.
    Kuroda T; Tanabe N; Kobayashi D; Wada Y; Murakami S; Nakano M; Narita I
    Rheumatol Int; 2012 Oct; 32(10):3155-62. PubMed ID: 21947375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.